Healthcare and Life Sciences

July 20, 2016 | 92 Pages | SKU: IRTNTR8628

Outlook of the global pain management drugs market

Technavio’s market research analyst predicts the global pain management drugs market to grow moderately at a CAGR of around 4% until 2020. The launch of several innovative combination therapies during the forecast period will help to foster the prospects for market growth. Also, factors such as the recent increase in older population and chronic conditions will play a significant role in the growth and development of this market.

The recent rise in the awareness of pain management drugs will help in the growth of this market until 2020. The acceptability of pain management drugs will rise during the forecast period due to increasing public awareness about the availability of treatments. This increase in the general awareness will lead to an increase in research funding for clinical and support services.

Segmentation by drug class and analysis of the pain management drugs market

  • Opioids
  • NSAIDs

In 2015, the Opioids segment dominated this market and accounted for more than 49% of the total market share. The presence of late-stage pipeline molecules is expected to drive the market despite the loss of patent exclusivity on major drugs.

Geographical segmentation of the pain management drugs market

  • Americas
  • APAC
  • Europe

In 2015, the Americas was the largest market for pain management drugs as it accounted for a market share of more than 52%. The market in the Americas is expected to grow at a slow pace during the forecast period due to intense competition from generics. However, the growth of this market in the Americas can be attributed to the presence of a strong pipeline and favorable regulatory scenario.

Competitive


July 20, 2016 | 60 Pages | SKU: IRTNTR9084

Overview of the global atherectomy devices market

Atherectomy is a minimally invasive surgical procedure for the plaque that blocks vein grafts or coronary arteries. The recent rise in the incidence of peripheral artery disease across the globe, especially among the aging population, has boosted the demand for atherectomy procedures during the forecast period. Since many medical facilities are using atherectomy procedures to treat the peripheral artery disease, it will increase the demand and sales of atherectomy devices in the next few years. Technavio’s market research analyst predicts that the global atherectomy devices market will grow at a CAGR of more than 5% by 2020.

Owing to technological advancements and product innovations, vendors have been compelled to replace traditional atherectomy devices with new technologies like laser-based atherectomy devices. These advanced devices are more efficient and have minimal complications.  Vendors have also come up with devices that offer advanced features such as improved physician controls, ergonomics, and manufacturability. For instance, Avinger’s advanced version of Pantheris lumivascular atherectomy system is the first image-guided atherectomy device. The increase in demand for such innovative devices among physicians will augment this market’s growth potential during the forecast period.

Segmentation by technology and analysis of the atherectomy devices market

  • Directional atherectomy
  • Rotational atherectomy
  • Orbital atherectomy
  • Laser atherectomy

Orbital atherectomy is an advanced technology that helps remove plaque in difficult-to-treat patient population. The high revolving speed of orbital atherectomy devices makes the tissue remains small for their harmless excretion through the circulatory system and restricts any possibility for distal embolic complications. These


July 20, 2016 | 60 Pages | SKU: IRTNTR9361

Overview of the global fractional flow reserve market

The market research analyst at Technavio has estimated that the global fractional flow reserve market will grow at an impressive CAGR of around 14% between the period of 2016 to 2020. The increasing need for the diagnosis of CAD (coronary artery disease) is one of the major drivers for market growth. This market forecast predicts the limited applications of standard coronary angiography as the primary reason for the increase in demand for new diagnosis techniques like FFR (fractional flow reserve). Though coronary angiogram is the standard procedure in the diagnosis of CAD, a clear picture of the severity of the disease can never be achieved. Moreover, its inaccuracy in predicting the exact lesion causing ischemia will also aid in the growth of this market in the next four years.

Recently, it has been observed that a number of companies have started entering this market and this factor is considered to be a major trend influencing this market’s growth in the forecast period. Gaining FDA (food and drug administration) approvals and the recent release of a number of new FFR products in the market are some of the factors impelling growth during the estimated period. Due to the entry of new vendors, end users will have numerous options to choose from and this will subsequently lead to the high penetration of FFR products over the next few years.

Segmentation by application and analysis of the fractional flow reserve market

  • Multi-vessel disease
  • Single-vessel disease

In terms of application, this market analysis predicts that the multi-vessel disease segment will dominate this market and will account for an impressive market share of about 63% by 2020. FFR measurement is extremely important for individuals suffering from multi-vessel disease as it completely alters the revascularization strategy


July 20, 2016 | 60 Pages | SKU: IRTNTR8771

Outlook of the Holter monitors market

Extensive research carried out by the analysts at Technavio has shown that the global Holter monitors market will grow at steadily a CAGR of more than 5% over the forecast period. Factors like the rising incidence of cardiac disorders such as bradycardia, ventricular fibrillation, cardiac arrest, and tachycardia are expected to propel the market for Holter monitors in the coming years. With aging, heart muscles lose their elasticity and ability to respond to different pressure rates which make older people more susceptible to cardiac disorders. The American Heart Association estimated that about 450,000 deaths in the US due to cardiac disorders each year. These factors make most individuals above the age of 60 susceptible to cardiac diseases. Moreover, it is estimated that close to 841 million people worldwide were of this age group in 2013, which will increase two-folds by 2050. Therefore, a rise in aging population will increase the prevalence of cardiac disorders, thereby bolstering this market’s growth prospects during the predicted period.

In this industry research report, the analysts have estimated factors such as the introduction and increasing adoption of innovative products with advanced technologies will positively affect this market in the coming years. Vendors are using advanced technologies to develop Holter monitors with additional features. For example, GE Healthcare's SEER 1000 is a multi-channel digital and wireless Holter recorder that allows easier cardiac data collection. This device has a customized app and is compatible with wireless technologies. Furthermore, the app offers visual guidance for lead placement and improved signal quality. Therefore, the launch of such technologically advanced products is envisaged to drive the market for Holter monitors during the forecast period.

Segmentation by end-user and analysis of the Holter


July 20, 2016 | 60 Pages | SKU: IRTNTR9274

Overview of the global testosterone replacement therapy market

Technavio’s market research analyst predicts that the global testosterone replacement therapy market will generate revenues of over USD 2 billion by the end of the estimated period. A key driver influencing the growth of this market is the increased prevalence of chronic diseases around the world. Low testosterone levels can cause chronic problems like diabetes, heart disease, and can even exacerbate conditions like rheumatoid arthritis. Since these chronic conditions lead to disorders in the hypothalamic-pituitary-gonadal axis, the demand for testosterone replacement therapy will increase significantly over the next few years. This recent increase in the number of individuals with low testosterone levels will have a positive impact on the market’s growth potential during the forecast period.

In this industry report, the analysts estimate factors like the availability selective androgen receptor modulators (SARMs) to spur market growth during the forecast period. Testosterone therapies are available in injectable form or delivery through the skin. The development and free availability of SARMs are considered a better treatment option for people with androgen deficiencies. Taken orally, SARMS elicit the desired response by targeting androgen receptors. The availability of effective drug delivery systems like SARMS will propel market growth until the end of 2020.

Segmentation by dosage form and analysis of the testosterone replacement therapy market

  • Gels
  • Injectables
  • Patches

In 2015, the gels segment accounted for the largest share of the testosterone replacement therapy market with approximately 66% market share. Gels are available in a semi-solid form and contain an active ingredient, which can be applied locally for


July 14, 2016 | 60 Pages | SKU: IRTNTR9771

Overview of the global RFID blood monitoring systems market

Market research analysts at Technavio have predicted that the global RFID blood monitoring systems market will show an impressive growth during the predicted period and post a CAGR of more than 16% by 2020. RFIDs are gradually replacing the use of 1D and 2D barcodes. Barcodes work only when the scanner is placed directly in front of the label and also do not offer durability. Whereas, RFID uses radio waves to communicate and does not require proper orientation of label and scanner. RFID tags are only required to be within the reading range of the reader, which will drive the efficiency of logistics in various applications including blood transfusions. Barcode is a read-only label where the data can never be changed after it is printed. However, in RFID tags, the data can be rewritten or modified as required. Moreover, RFID tags are durable and reusable, and RFID technology is more secure as the information can be encrypted. These advantages of RFID over barcode scanners will be one of the major factors that will have a positive impact on the demand for this market in the coming years.

There is a growing need to reduce medical wastage and to improve the efficiencies of manual blood monitoring systems that normally faces several challenges such as medical errors and slow speed in process. RFID technology enables transforming the supply chain automation and visibility and also helps shippers to track assets and shipments in real time. Replacing manual scans, RFID helps blood banks to save considerable time in all processes


Pages